127 related articles for article (PubMed ID: 17910839)
1. [Bone metastases from unknown primary. FDG-PET detection of two synchronous tumors].
Cuenca Cuenca JI; Borrego Dorado I; Rodríguez Rodríguez JR; Navarro González E; Vázquez Albertino R
Rev Esp Med Nucl; 2007; 26(5):297-302. PubMed ID: 17910839
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 18FDG-PET with 99mTc-HMDP scintigraphy for the detection of bone metastases in patients with breast cancer.
Abe K; Sasaki M; Kuwabara Y; Koga H; Baba S; Hayashi K; Takahashi N; Honda H
Ann Nucl Med; 2005 Oct; 19(7):573-9. PubMed ID: 16363622
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. Detection of bone metastases in thyroid cancer patients: bone scintigraphy or 18F-FDG PET?
Phan HT; Jager PL; Plukker JT; Wolffenbuttel BH; Dierckx RA; Links TP
Nucl Med Commun; 2007 Aug; 28(8):597-602. PubMed ID: 17625381
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and patterns of bone metastases detected with positron emission tomography using F-18 FDG.
Nakamoto Y; Osman M; Wahl RL
Clin Nucl Med; 2003 Apr; 28(4):302-7. PubMed ID: 12642709
[TBL] [Abstract][Full Text] [Related]
6. Bone metastasis versus bone marrow metastasis? Integration of diagnosis by (18)F-fluorodeoxyglucose positron emission/computed tomography in advanced malignancy with super bone scan: two case reports and literature review.
Lin CY; Chen YW; Chang CC; Yang WC; Huang CJ; Hou MF
Kaohsiung J Med Sci; 2013 Apr; 29(4):229-33. PubMed ID: 23541269
[TBL] [Abstract][Full Text] [Related]
7. Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.
Iwata M; Kasagi K; Misaki T; Matsumoto K; Iida Y; Ishimori T; Nakamoto Y; Higashi T; Saga T; Konishi J
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):491-8. PubMed ID: 14666387
[TBL] [Abstract][Full Text] [Related]
8. [Papillary thyroid carcinoma synchronous with breast cancer: an incidental finding in an (18)F-FDG PET-CT study carried out in a search for occult breast cancer].
Banzo J; Ubieto MA; González C; Razola P; Tardín L; Andrés A; Santapau A; Parra A; Rambalde EF; Prats E
Rev Esp Med Nucl Imagen Mol; 2012; 31(4):213-5. PubMed ID: 23067689
[TBL] [Abstract][Full Text] [Related]
9. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
Qiu ZL; Xue YL; Song HJ; Luo QY
Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 18F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer.
Ito S; Kato K; Ikeda M; Iwano S; Makino N; Tadokoro M; Abe S; Nakano S; Nishino M; Ishigaki T; Naganawa S
J Nucl Med; 2007 Jun; 48(6):889-95. PubMed ID: 17504877
[TBL] [Abstract][Full Text] [Related]
12. Metastatic thyroid cancer occurring as an unknown primary lesion: the role of F-18 FDG positron emission tomography.
Dede F; Ajoedi ND; Ansari SM; Jana S; Heiba SI; Abdel-Dayem HM
Clin Nucl Med; 2001 May; 26(5):396-9. PubMed ID: 11317017
[TBL] [Abstract][Full Text] [Related]
13. Role of 2-deoxy-2-[F-18] fluoro-D-glucose positron emission tomography in the management of bone and soft-tissue metastases.
Yanagawa T; Shinozaki T; Iizuka Y; Takagishi K; Watanabe H
J Bone Joint Surg Br; 2010 Mar; 92(3):419-23. PubMed ID: 20190315
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases.
Chang CY; Gill CM; Joseph Simeone F; Taneja AK; Huang AJ; Torriani M; Bredella MA
Acta Radiol; 2016 Jan; 57(1):58-65. PubMed ID: 25533313
[TBL] [Abstract][Full Text] [Related]
15. Detection of bone marrow metastases by FDG-PET and missed by bone scintigraphy in widespread melanoma.
Aydin A; Yu JQ; Zhuang H; Alavi A
Clin Nucl Med; 2005 Sep; 30(9):606-7. PubMed ID: 16100478
[TBL] [Abstract][Full Text] [Related]
16. The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor.
Rusthoven KE; Koshy M; Paulino AC
Cancer; 2004 Dec; 101(11):2641-9. PubMed ID: 15517576
[TBL] [Abstract][Full Text] [Related]
17. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
[TBL] [Abstract][Full Text] [Related]
18. The detection of unknown primary tumors in patients with cervical metastases by dual-head positron emission tomography.
Stokkel MP; Terhaard CH; Hordijk GJ; van Rijk PP
Oral Oncol; 1999 Jul; 35(4):390-4. PubMed ID: 10645404
[TBL] [Abstract][Full Text] [Related]
19. [Utility of PET-18FDG in primary tumor site in a patient with cerebral metastases].
Suárez Fernández JP; Serna Macías JA; Domínguez Grande ML; Liaño H; Pozo MA; Maldonado Suárez A
Rev Esp Med Nucl; 2005; 24(4):253. PubMed ID: 16122410
[No Abstract] [Full Text] [Related]
20. Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions.
Cook GJ; Houston S; Rubens R; Maisey MN; Fogelman I
J Clin Oncol; 1998 Oct; 16(10):3375-9. PubMed ID: 9779715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
